← Back to headlines
Hims CEO Responds to FTC Suit, Predicts GLP-1 Price Drop
The CEO of Hims has responded to a lawsuit from the FTC and anticipates that prices for GLP-1 drugs will fall to $40-$50, according to CNBC.
18 Aug, 18:44 — 18 Aug, 18:44
Sources
Showing 1 of 1 sources
